APA (7th ed.) Citation

Andersen, J. A. S., Spatzek, A. D., Vilstrup, M. H., Grupe, P., Hess, S., Holdgaard, P. C., . . . Hildebrandt, M. G. (2022). The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma. European Journal of Nuclear Medicine & Molecular Imaging, 49(7), 2342. https://doi.org/10.1007/s00259-022-05704-0

Chicago Style (17th ed.) Citation

Andersen, Jesper A. S., Anders D. Spatzek, Mie H. Vilstrup, Peter Grupe, Søren Hess, Paw C. Holdgaard, Lars Bastholt, Oke Gerke, and Malene G. Hildebrandt. "The Diagnostic Accuracy and Clinical Impact of FDG-PET/CT Follow-up for Patients on Adjuvant Immunotherapy for High-risk Malignant Melanoma." European Journal of Nuclear Medicine & Molecular Imaging 49, no. 7 (2022): 2342. https://doi.org/10.1007/s00259-022-05704-0.

MLA (9th ed.) Citation

Andersen, Jesper A. S., et al. "The Diagnostic Accuracy and Clinical Impact of FDG-PET/CT Follow-up for Patients on Adjuvant Immunotherapy for High-risk Malignant Melanoma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 49, no. 7, 2022, p. 2342, https://doi.org/10.1007/s00259-022-05704-0.